CervoMed
CRVO
17 hedge funds and large institutions have $1.76M invested in CervoMed in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
21% more funds holding
Funds holding: 14 → 17 (+3)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% less capital invested
Capital invested by funds: $1.77M → $1.76M (-$7K)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$95.3K |
| 2 |
Renaissance Technologies
New York
|
+$46K |
| 3 |
Goldman Sachs
New York
|
+$26.5K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$10.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$10.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WTC
WhitTier Trust Company
Reno,
Nevada
|
-$53K |
| 2 |
SRCM
Swift Run Capital Management
Charlottesville,
Virginia
|
-$27K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$19K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$10.7K |
| 5 |
VF
Virtu Financial
New York
|
-$5.12K |
CRVO Hedge Fund Activity: Q3 2018 in Review
17 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q3 2018, worth a combined $1.76M — down 0.4% from $1.77M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CRVO positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $95.3K. The largest seller was WhitTier Trust Company, cutting an estimated $53K.
- 17 institutional investors held CervoMed (CRVO) as of Q3 2018, up from 14 in Q2 2018.
- Funds reported $1.76M of CervoMed stock for Q3 2018, down 0.4% quarter-over-quarter.
- 4 funds opened new CervoMed positions in Q3 2018 and 1 closed out, a net change of +3 holders.
- The largest CervoMed buyer in Q3 2018 was Millennium Management, an estimated $95.3K added.
- The largest CervoMed seller in Q3 2018 was WhitTier Trust Company, an estimated $53K sold.
Based on aggregated 13F filings for Q3 2018.